Diana Al Delbany
Overview
Explore the profile of Diana Al Delbany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei Y, Duong M, Krivec N, Janssens C, Regin M, Huyghebaert A, et al.
Cell Prolif
. 2025 Feb;
:e13813.
PMID: 39908990
Chromosomal abnormalities acquired during cell culture can compromise the differentiation potential of human pluripotent stem cells (hPSCs). In this work, we identified a diminished differentiation capacity to retinal progenitor cells...
2.
Krivec N, Couvreu de Deckersberg E, Lei Y, Al Delbany D, Regin M, Verhulst S, et al.
Cell Death Dis
. 2024 Nov;
15(11):852.
PMID: 39572522
Gain of 1q is a highly recurrent chromosomal abnormality in human pluripotent stem cells. In this work, we show that gains of 1q impact the differentiation capacity to derivates of...
3.
Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M, et al.
Cells
. 2024 Aug;
13(16).
PMID: 39195283
Human pluripotent stem cells (hPSCs) are pivotal in regenerative medicine, yet their in vitro expansion often leads to genetic abnormalities, raising concerns about their safety in clinical applications. This study...
4.
Lei Y, Al Delbany D, Krivec N, Regin M, Couvreu de Deckersberg E, Janssens C, et al.
Stem Cell Reports
. 2024 Mar;
19(4):562-578.
PMID: 38552632
Human pluripotent stem cell (hPSC) cultures are prone to genetic drift, because cells that have acquired specific genetic abnormalities experience a selective advantage in vitro. These abnormalities are highly recurrent...
5.
Al Delbany D, Robert V, Dubois-Vedrenne I, Del Prete A, Vernimmen M, Radi A, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638484
CCRL2 belongs to the G protein-coupled receptor family and is one of the three chemerin receptors. It is considered as a non-signaling receptor, presenting chemerin to cells expressing the functional...
6.
Dubois-Vedrenne I, Al Delbany D, De Henau O, Robert V, Vernimmen M, Langa F, et al.
Oncotarget
. 2021 Sep;
12(19):1903-1919.
PMID: 34548907
Chemerin, a multifunctional protein acting through the receptor ChemR23/CMKLR1, is downregulated in various human tumors and was shown to display antitumoral properties in mouse models of cancer. In the present...
7.
Dubois-Vedrenne I, De Henau O, Robert V, Langa F, Javary J, Al Delbany D, et al.
Front Oncol
. 2020 Jul;
10:977.
PMID: 32656083
[This corrects the article DOI: 10.3389/fonc.2019.01253.].
8.
Dubois-Vedrenne I, De Henau O, Robert V, Langa F, Javary J, Al Delbany D, et al.
Front Oncol
. 2019 Dec;
9:1253.
PMID: 31803622
Chemerin is a multifunctional protein acting mainly through the G protein-coupled receptor ChemR23/CMKLR1/Chemerin. Its expression is frequently downregulated in human tumors, including in melanoma and squamous cell carcinoma of the...